Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/31/2026

1. NVDA
2. PCG
3. AMZN
4. AVGO
5. AAPL
6. ALNY
7. CNS
8. STLA
9. EC
10. SRE

Go back to Context Therapeutics Acquires Phase 1-ready T cell Engager CT-95
(NASDAQ: CNTX) Delayed: 0.39 +0.01 (2.63%)
Previous Close $0.38    52 Week High $ 
Open $0.39    52 Week Low $ 
Day High $0.40    P/E N/A 
Day Low $0.37    EPS $ 
Volume 1,280,725       

(NASDAQ: CNTX) Delayed: 0.39 +0.01 (2.63%)
Previous Close $0.38    52 Week High $ 
Open $0.39    52 Week Low $ 
Day High $0.40    P/E N/A 
Day Low $0.37    EPS $ 
Volume 1,280,725